239 related articles for article (PubMed ID: 34107385)
1. Research progress of dual inhibitors targeting crosstalk between histone epigenetic modulators for cancer therapy.
Duan YC; Zhang SJ; Shi XJ; Jin LF; Yu T; Song Y; Guan YY
Eur J Med Chem; 2021 Oct; 222():113588. PubMed ID: 34107385
[TBL] [Abstract][Full Text] [Related]
2. Deciphering the interplay of histone post-translational modifications in cancer: Co-targeting histone modulators for precision therapy.
Kawaf RR; Ramadan WS; El-Awady R
Life Sci; 2024 Jun; 346():122639. PubMed ID: 38615747
[TBL] [Abstract][Full Text] [Related]
3. Development and classes of epigenetic drugs for cancer.
Dhanak D; Jackson P
Biochem Biophys Res Commun; 2014 Dec; 455(1-2):58-69. PubMed ID: 25016182
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic small molecule modulators of histone and DNA methylation.
Hauser AT; Robaa D; Jung M
Curr Opin Chem Biol; 2018 Aug; 45():73-85. PubMed ID: 29579619
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic Targets and their Inhibitors in Cancer Therapy.
Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS
Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481
[TBL] [Abstract][Full Text] [Related]
6. DNA Methylation Targeting: The DNMT/HMT Crosstalk Challenge.
Castillo-Aguilera O; Depreux P; Halby L; Arimondo PB; Goossens L
Biomolecules; 2017 Jan; 7(1):. PubMed ID: 28067760
[TBL] [Abstract][Full Text] [Related]
7. Dual inhibitors of HDAC and other epigenetic regulators: A novel strategy for cancer treatment.
Shirbhate E; Singh V; Jahoriya V; Mishra A; Veerasamy R; Tiwari AK; Rajak H
Eur J Med Chem; 2024 Jan; 263():115938. PubMed ID: 37989059
[TBL] [Abstract][Full Text] [Related]
8. Successful strategies in the discovery of small-molecule epigenetic modulators with anticancer potential.
Bayo J; Dalvi MP; Martinez ED
Future Med Chem; 2015; 7(16):2243-61. PubMed ID: 26510529
[TBL] [Abstract][Full Text] [Related]
9. Epigenetically Active Drugs Inhibiting DNA Methylation and Histone Deacetylation.
Chistiakov DA; Myasoedova VA; Orekhov AN; Bobryshev YV
Curr Pharm Des; 2017; 23(8):1167-1174. PubMed ID: 27774908
[TBL] [Abstract][Full Text] [Related]
10. Clinical advances in targeting epigenetics for cancer therapy.
Feng S; De Carvalho DD
FEBS J; 2022 Mar; 289(5):1214-1239. PubMed ID: 33545740
[TBL] [Abstract][Full Text] [Related]
11. Histone methyltransferase inhibitors: novel epigenetic agents for cancer treatment.
Zagni C; Chiacchio U; Rescifina A
Curr Med Chem; 2013; 20(2):167-85. PubMed ID: 23210854
[TBL] [Abstract][Full Text] [Related]
12. Trials with 'epigenetic' drugs: an update.
Nebbioso A; Carafa V; Benedetti R; Altucci L
Mol Oncol; 2012 Dec; 6(6):657-82. PubMed ID: 23103179
[TBL] [Abstract][Full Text] [Related]
13. Natural Product Inhibitors of Histone Deacetylases as New Anticancer Agents.
Hanikoglu A; Hanikoglu F; Ozben T
Curr Protein Pept Sci; 2018; 19(3):333-340. PubMed ID: 28059044
[TBL] [Abstract][Full Text] [Related]
14. Targeting epigenetic reader and eraser: Rational design, synthesis and in vitro evaluation of dimethylisoxazoles derivatives as BRD4/HDAC dual inhibitors.
Zhang Z; Hou S; Chen H; Ran T; Jiang F; Bian Y; Zhang D; Zhi Y; Wang L; Zhang L; Li H; Zhang Y; Tang W; Lu T; Chen Y
Bioorg Med Chem Lett; 2016 Jun; 26(12):2931-2935. PubMed ID: 27142751
[TBL] [Abstract][Full Text] [Related]
15. Small-molecular modulators of cancer-associated epigenetic mechanisms.
Itoh Y; Suzuki T; Miyata N
Mol Biosyst; 2013 May; 9(5):873-96. PubMed ID: 23511667
[TBL] [Abstract][Full Text] [Related]
16. Bromodomains: Structure, function and pharmacology of inhibition.
Ferri E; Petosa C; McKenna CE
Biochem Pharmacol; 2016 Apr; 106():1-18. PubMed ID: 26707800
[TBL] [Abstract][Full Text] [Related]
17. Genistein Induces Alterations of Epigenetic Modulatory Signatures in Human Cervical Cancer Cells.
Sundaram MK; Ansari MZ; Al Mutery A; Ashraf M; Nasab R; Rai S; Rais N; Hussain A
Anticancer Agents Med Chem; 2018; 18(3):412-421. PubMed ID: 28925878
[TBL] [Abstract][Full Text] [Related]
18. New and under explored epigenetic modulators in search of new paradigms.
Alam MA; Reddy YS; Ali MA
Med Chem; 2015; 11(3):271-85. PubMed ID: 25256243
[TBL] [Abstract][Full Text] [Related]
19. Targeting Epigenetics in Cancer.
Bennett RL; Licht JD
Annu Rev Pharmacol Toxicol; 2018 Jan; 58():187-207. PubMed ID: 28992434
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical application.
Santini V; Gozzini A; Ferrari G
Curr Drug Metab; 2007 May; 8(4):383-93. PubMed ID: 17504226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
